Company research / ADGM
Adagio Medical Holdings, Inc. (ADGM)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Adagio Medical Holdings, Inc. reported revenue of $0. Over the twelve months to 2026-06-30, revenue was $0.
Key ratios (year ended 2025-12-31)
-202.3%
Return on year-end equity
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.
Annual financials
| Period ended | TTM to 2026-06-30 | 2025-12-31 | 2024-12-31 | 2024-07-30 | 2023-12-31 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | n/a | n/a | $300.0K |
| Cost of Revenue | n/a | $684.0K | n/a | n/a | $1.31M |
| Gross Profit (computed) | n/a | -$684.0K | n/a | n/a | -$1.01M |
| R&D Expense | $10.20M | $10.64M | n/a | n/a | $15.40M |
| Operating Income | -$19.82M | -$21.89M | n/a | n/a | -$27.94M |
| Depreciation & Amortization | $839.0K | $970.0K | n/a | n/a | $532.0K |
| EBITDA | -$18.98M | -$20.92M | n/a | n/a | -$27.41M |
| Net Income | -$27.14M | -$25.08M | n/a | n/a | -$36.59M |
| EPS (Diluted) | n/a | -$1.51 | n/a | n/a | -$48.16 |
| Total Assets | $33.88M | $43.25M | $48.45M | n/a | $6.83M |
| Total Liabilities | $34.30M | $30.85M | $28.54M | n/a | $47.38M |
| Long-Term Debt | $24.84M | $21.04M | $17.18M | n/a | $38.27M |
| Shareholders' Equity | -$415.0K | $12.40M | $19.91M | -$148.31M | -$132.02M |
| Cash & Equivalents | $7.74M | $17.11M | $20.59M | n/a | $1.38M |
| Operating Cash Flow | -$16.53M | -$19.01M | n/a | n/a | -$25.65M |
| Capital Expenditures | $37.0K | $374.0K | n/a | n/a | $333.0K |
| Free Cash Flow | -$16.57M | -$19.39M | n/a | n/a | -$25.98M |
| Shares Outstanding | 22.21M | 22.21M | 15.20M | 779.9K | 779.9K |
| Dividends Per Share | n/a | n/a | n/a | n/a | $0.00 |
| Weighted Average Diluted Shares | n/a | 16.58M | n/a | n/a | n/a |
| EPS (Basic) | n/a | -$1.51 | n/a | n/a | -$48.16 |